FDA Inspection 1278103 — Seqirus Vaccines Limited
The FDA completed an inspection of Seqirus Vaccines Limited on June 10, 2025 in Liverpool. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 10, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Liverpool (United Kingdom)